Efficacy of dry extract of ivy leaves in children with bronchial asthma - A review of randomized controlled trials

Phytomedicine

Volumn 10, Issue 2-3, 2003, Pages 213-220

  Hofmann, D ^a   Hecker, M ^b   Volp A ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Engelhard Arzneimittel GmbH Co KG   (Germany)

^c Psy Consult Scientific Services   (Germany)

Author keywords

Bronchial asthma; Children; Ivy leaves (Hedera helix); Randomised controlled trials

Indexed keywords

HEDELIX; PROSPAN; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ASTHMA; ATOPIC DERMATITIS; BODY PLETHYSMOGRAPHY; CHILD; CHILDHOOD DISEASE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IVY; MEDICINAL PLANT; PHYTOTHERAPY; PLANT LEAF; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPIROMETRY; SUPPOSITORY; SYRUP;

ARGYROSOMUS REGIUS; HEDERA; HEDERA HELIX;

EID: 0037360854     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/094471103321659979     Document Type: Review

References (29)

1. Bedir E, Kirmizipekmez H, Sticher O, Calis I (2000) Triterpene saponins from the fruits of Hedera helix. Phytochemistry 53: 905-909
2. Brown R (2001) Behavioral issues in asthma management. Allergy Asthma Proc 22: 67-69
3. Bundesgesundheitsamt (1988) Monographie - Hederae helicis folium, Efeublätter. Bundesanzeiger 122, July 6, 1988
4. Burney PG, Luczynska C, Chinn S, Jarvis D (1994) The European Community Respiratory Health Survey. Eur Respir J 7: 954-960
5. Cioaca C, Margineanu C, Cucu V (1978) The saponins of Hedera helix with antibacterial activity. Pharmazie 33: 609-610
6. Düchtel-Brühl A (1976) Ergebnisse der Behandlung spastischer Bronchitiden im Kindesalter mit Prospan. Medizinische Welt 27: 481
7. Gulyas A, Repges R, Dethlefsen U (1997) Konsequente Therapie chronisch obstruktiver Atemwegserkrankungen bei Kindern. Atemwegs- und Lungenkrankheiten 23: 291-294
8. Haen E (1996) Pharmacological activities of Thymus vulgaris and Hedera helix. Phytomedicine 3 Suppl 1: 144
9. Hasselblad V, Kong DF (2001) Statistical methods for comparison to placebo in active-control trials. Drug Inf J 35: 435-449
10. Hauck WW, Anderson P (1999) Some issues in the design and analysis of equivalence trials. Drug Inf J 33: 109-118
11. International Conference on Harmonization (2000) ICH topic E10 - Choice of control group in clinical trials (CPMP/ICH/364/96). European Agency for the Evaluation of Medical Products, London, UK, July 27
12. Konietzko N, Fabel H (1996) Weißbuch Lunge - Die Lunge und ihre Erkrankungen: Zur Lage der Pneumologie in Deutschland. Thieme, Stuttgart
13. Landgrebe H, Runkel F, Hecker M (1999) Efeuextrakte Wirkung und Anwendung einer alten Heilpflanze. Pharm Ztg 144: 2723-2727
14. Lemmer B (2000) Antitussiva und Expektorantien. In Pfaffrath D (ed) Arzneiverordnungs-Report 2000, pp 234-256, Springer, Berlin, Heidelberg, New York
15. Lemmer B (2001) Antitussiva und Expektorantien. In Pfaffrath D (ed) Arzneiverordnungs-Report 2001, pp 264-284, Springer, Berlin, Heidelberg, New York
16. Mansfeld H-J, Höhre H, Repges R, Dethlefsen U (1997) Sekretolyse und Bronchospasmolyse - Klinische Studie: Behandlung von Kindern mit chronisch obstruktiven Atemwegserkrankungen. TW Pädiatrie 8: 155-157
17. Mansfeld H-J, Höhre H, Repges R, Dethlefsen U (1998) Therapie des Asthma bronchiale mit Efeublätter-Trockenextrakt. Münchner Medizinische Wochenschrift 140: 26-30
18. McGuire A, Irwin DE, Fenn P, Gray A, Anderson P, Lovering A, MacGowan A (2001) The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales. Value Health 4: 370-375
19. Meyer-Wegener J, Liebscher K, Hettich M, Kastner H-G (1993) Efeu versus Ambroxol bei chronischer Bronchitis. ZFA. Zeitschrift für Allgemeinmedizin 69: 61-66
20. Momas I, Dartiguenave C, Fauroux B, Bourdais M, Poinsard R, Grimfeld A, Just J (1998) Prevalence of asthma or respiratory symptoms among children attending primary schools in Paris. Pediatr Pulmonol 26: 106-112
21. Montnemery P, Bengtsson P, Elliot A, Lindholm LH, Nyberg P, Lofdahl CG (2001) Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir Med 95: 744-752
22. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R (1999) Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 21: 576-591
23. Poole PJ, Black PN (2001) Mucolytic agents for chronic bronchitis (Cochrane Review). In The Cochrane Library, Update Software, Oxford
24. Schmidt W (1976) Prospan - Bronchosekretolytikum und Antitussivum. ZFA. Zeitschrift für Allgemeinmedizin 52: 546-548
25. Schulz V, Hänsel R, Tyler V (2001) Rational phytotherapy - a physician's guide to herbal medicine. Springer, Berlin, Heidelberg, New York
26. Sunyer J (2001) Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 17: 1024-1033
27. Trute A, Gross J, Mutschler E, Nahrstedt A (1997) In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Medica 63: 125-129
28. Unkauf M, Friedrich M (2000) Bronchitis bei Kindern - klinische Studie mit Efeublätter-Trockenextrakt. Der Bayerische Internist 4 Suppl: 2-4
29. Vollmer WM, Osborne ML, Buist AS (1998) 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med 157: 1079-1084